Table of Contents
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Peripheral Embolic Protection Devices Overview 7
3 Products under Development 8
3.1 Peripheral Embolic Protection Devices – Pipeline Products by Stage of Development 8
3.2 Peripheral Embolic Protection Devices – Pipeline Products by Segment 9
3.3 Peripheral Embolic Protection Devices – Pipeline Products by Territory 10
3.4 Peripheral Embolic Protection Devices – Pipeline Products by Regulatory Path 11
3.5 Peripheral Embolic Protection Devices – Pipeline Products by Estimated Approval Date 12
3.6 Peripheral Embolic Protection Devices – Ongoing Clinical Trials 13
4 Peripheral Embolic Protection Devices – Pipeline Products under Development by Companies 14
4.1 Peripheral Embolic Protection Devices Companies – Pipeline Products by Stage of Development 14
4.2 Peripheral Embolic Protection Devices – Pipeline Products by Stage of Development 15
5 Peripheral Embolic Protection Devices Companies and Product Overview 16
5.1 Abbott Vascular Inc Company Overview 16
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Artio Medical Company Overview 17
5.2.1 Artio Medical Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 Avantec Vascular Corp Company Overview 18
5.3.1 Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 BTG Plc Company Overview 19
5.4.1 BTG Plc Pipeline Products & Ongoing Clinical Trials Overview 19
5.5 Capture Vascular Inc Company Overview 20
5.5.1 Capture Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 Cardio-Flow Ltd. Company Overview 22
5.6.1 Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
5.7 Cardiovascular Systems Inc Company Overview 23
5.7.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 23
5.8 Emboline, Inc. Company Overview 25
5.8.1 Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.9 Filterlex Medical Ltd Company Overview 28
5.9.1 Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
5.10 Innovative Cardiovascular Solutions, LLC Company Overview 29
5.10.1 Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
5.11 Innovia LLC Company Overview 32
5.11.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 32
5.12 Javelin Medical Ltd Company Overview 33
5.12.1 Javelin Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
5.13 Keystone Heart Ltd Company Overview 36
5.13.1 Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
5.14 Medtronic plc Company Overview 38
5.14.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 38
5.15 MIV Therapeutics Inc Company Overview 39
5.15.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.16 Neurosonix Ltd. Company Overview 40
5.16.1 Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
5.17 Protembis GmbH Company Overview 41
5.17.1 Protembis GmbH Pipeline Products & Ongoing Clinical Trials Overview 41
5.18 University of Minnesota Company Overview 42
5.18.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 42
5.19 University of Toledo Company Overview 43
5.19.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 43
6 Peripheral Embolic Protection Devices- Recent Developments 44
6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 44
6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 46
6.3 Nov 07, 2019: Penumbra reports third quarter 2019 financial results 47
6.4 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 48
6.5 Oct 23, 2019: Edwards Lifesciences reports third quarter results 50
7 Appendix 101
7.1 Methodology 101
7.2 About GlobalData 104
7.3 Contact Us 104
7.4 Disclaimer 104
Table 1: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
Table 2: Peripheral Embolic Protection Devices - Pipeline Products by Segment
Table 3: Peripheral Embolic Protection Devices - Pipeline Products by Territory
Table 4: Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
Table 5: Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
Table 6: Peripheral Embolic Protection Devices - Ongoing Clinical Trials
Table 7: Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development
Table 8: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Status
Table 11: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Description
Table 12: Artio Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Blockstent Microcatheter - Product Status
Table 14: Blockstent Microcatheter - Product Description
Table 15: Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Peripheral Embolization Device - Product Status
Table 17: Peripheral Embolization Device - Product Description
Table 18: BTG Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: EKOS Control Unit - New - Product Status
Table 20: EKOS Control Unit - New - Product Description
Table 21: Capture Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Megavac - BTK - Product Status
Table 23: Megavac - BTK - Product Description
Table 24: Thrombowire Clot Retractor - BTK - Product Status
Table 25: Thrombowire Clot Retractor - BTK - Product Description
Table 26: Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 27: EmboPRO EPD - Product Status
Table 28: EmboPRO EPD - Product Description
Table 29: Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: WIRION EPD System - LE Atherectomy - Product Status
Table 31: WIRION EPD System - LE Atherectomy - Product Description
Table 32: Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Emboliner - Product Status
Table 34: Emboliner - Product Description
Table 35: Emboline, Inc. - Ongoing Clinical Trials Overview
Table 36: Emboliner - A Prospective, Non-randomized, Multi-center, Open-label Clinical Investigation to Assess the Safety and Technical Performance of the Emboliner Embolic Protection Catheter
Table 37: Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 38: CAPTIS - Product Status
Table 39: CAPTIS - Product Description
Table 40: Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 41: EMBLOK Embolic Protection System - Product Status
Table 42: EMBLOK Embolic Protection System - Product Description
Table 43: Innovative Cardiovascular Solutions, LLC - Ongoing Clinical Trials Overview
Table 44: EMBLOK Embolic Protection System - European Study Evaluating the EMBLOK Cerebral Embolic Protection System During Transcatheter Aortic Valve Replacement (TAVR)
Table 45: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Permanently Implantable Embolic Balloon - Product Status
Table 47: Permanently Implantable Embolic Balloon - Product Description
Table 48: Javelin Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Vine - Product Status
Table 50: Vine - Product Description
Table 51: Javelin Medical Ltd - Ongoing Clinical Trials Overview
Table 52: Vine - Carotid Artery Implant for Trapping Upstream Emboli (CAPTURE 2) for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants
Table 53: Vine - Carotid Artery Implant for Trapping Upstream Emboli for Preventing Stroke in Atrial Fibrillation Patients
Table 54: Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 55: TriGuard 3 - Product Status
Table 56: TriGuard 3 - Product Description
Table 57: TriGuard Cerebral Protection Device - Product Status
Table 58: TriGuard Cerebral Protection Device - Product Description
Table 59: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
List of Figures
Figure 1: Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development
Figure 2: Peripheral Embolic Protection Devices - Pipeline Products by Segment
Figure 3: Peripheral Embolic Protection Devices - Pipeline Products by Territory
Figure 4: Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path
Figure 5: Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date
Figure 6: Peripheral Embolic Protection Devices - Ongoing Clinical Trials
【免責事項】
https://www.marketreport.jp/reports-disclaimer